Exploratory Clinical Efficacy and Patient-Reported Outcomes from NOVA: A Randomized Controlled Study of Intravenous Natalizumab 6-Week Dosing Versus Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS（2023）
关键词
Walking speed,Manual dexterity,Cognitive processing speed,Patient-reported outcomes,Q6W dosing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要